(Total Views: 207)
Posted On: 11/15/2022 11:16:07 AM
Post# of 44868
Cancer Breakthrough: BriaCell (Nasdaq: $BCTX) reports disease control, tumor shrinkage and potential survival benefit among 70% of the patients enrolled in its 2021-2022 group of advanced breast cancer patients!
New CEO Interview https://yhoo.it/3EzQmij
#Stocks #Nasdaq $BCTX
New CEO Interview https://yhoo.it/3EzQmij
#Stocks #Nasdaq $BCTX
(0)
(0)
Scroll down for more posts ▼
